Pharmaceutical
Mistral Pharma Inc. , announces that earlier today, it filed a notice of intention to make a proposal to its creditors under the Bankruptcy and Insolvency Act. The Corporation filed the notice in order to facilitate ongoing negotiations concerning the te
11:34 Jun 13, 2008
Mistral Pharma Inc. , announces that earlier today, it filed a notice of intention to make a proposal to its creditors under the Bankruptcy and Insolvency Act. The Corporation filed the notice in order to facilitate ongoing negotiations concerning the te
11:30 Jun 13, 2008
Alexion Pharmaceuticals, Inc. today announced that Vikas Sinha, Senior Vice President and Chief Financial Officer of Alexion Pharmaceuticals, will present at the William Blair 28th Annual Growth Stock Conference inChicago at 9:10 a.m., local time on Thur
11:03 Jun 13, 2008
CardioDynamics , the innovator and leader of Impedance Cardiography technology, has scheduled a conference call and Internet webcast for Tuesday, July 1, 2008, at 4:30 p.m. EDT to discuss the Company's financial results for second quarter 2008. The call
10:13 Jun 13, 2008
recently received the American Stroke Association's Get With The Guidelines-Stroke Gold Performance Achievement Award. The award recognizes the Alexian Brothers Hospital Network's commitment and success in implementing a higher standard of stroke care by
09:23 Jun 13, 2008
As of June 11, 2008 EyeCity.com, Inc. has undergone a change in ownership that is going to completely revamp the company and move the corporation into a new and exciting direction. Currently a very tight and secure team of corporate individuals are in pr
09:03 Jun 13, 2008
Long and costly product development cycles make it essential for pharmaceutical companies to maximize limited staff and resources to the development of compounds with the greatest potential market value. Leading companies are integrating commercial insig
08:53 Jun 13, 2008
Protherics PLC announces Holding(s) in Company - 1
08:13 Jun 13, 2008
Elekta, a world-class leader in advanced radiation therapy and radiosurgery, has created a three-dimensional virtual patient clinic, enabling clinicians, patients and the general public a unique opportunity to familiarize themselves with Elekta's product
08:03 Jun 13, 2008
Market competition is mounting to win the time, attention and interest of the most highly qualified clinical investigators. Companies that develop depth and skill in winning clinical investigators to their studies win an advantage in bringing their produ
08:03 Jun 13, 2008
Protherics PLC announce Director/PDMR Shareholding
07:56 Jun 13, 2008
Smith & Nephew Plc - Transaction in Own Shares
07:48 Jun 13, 2008
Digirad Corporation , a leading provider of medical diagnostic imaging products and services to physicians' offices, hospitals and imaging centers, today announced that Chief Executive Mark Casner will be presenting at CapStone Investments' Second Annual
07:43 Jun 13, 2008
Disc Motion Technologies announced the completion of the first surgical procedure to implant the True Total Spinal Motion Segment System ), the first total joint replacement system for the lumbar spine, featuring an artificial lumbar disc and posterior d
07:23 Jun 13, 2008
is needed to address the funding issues and to modernize Medicare's payment system for hospice.
07:13 Jun 13, 2008
VANCOUVER, June 13 /PRNewswire-FirstCall/ - Angiotech Pharmaceuticals, Inc. , a global specialty pharmaceutical and medical device company, today announced the market launch of Quill SRS MONODERM. The product will be available immediately for distributio
07:13 Jun 13, 2008
A new "hospital report card" by the Department of Veterans Affairs gives the Department's health care system high marks, with VA facilities often outscoring private-sector health plans in standards commonly accepted by the health care industry.
07:03 Jun 13, 2008
SuperGen Inc. , a pharmaceutical company dedicated to the discovery, rapid development and commercialization of therapies for solid tumors and hematological malignancies, today announced at the 13th Congress of the European Hematology Association inCopen
06:53 Jun 13, 2008
Exelixis, Inc. today reported preliminary phase 1 data from an ongoing trial of XL228 in patients with chronic myelogenous leukemia orPhiladelphia chromosome-positive acute lymphocytic leukemia who are resistant to or intolerant of the approved BCR-ABL i
06:53 Jun 13, 2008
Polydex Pharmaceuticals Limited has today reported financial results of operations for the first quarter of fiscal 2009, ending April 30, 2008.
06:50 Jun 13, 2008
73650 - 73669 of 82819 Stories
<<
<
Next 20 Pharmaceutical
>
>>
Search News
Daily News
